Advancing Precision Therapies in Neurogenetic Disorders and the Treatment of Medically Refractory Epilepsies
Neuropediatrics · 01.04.2025 · 56 (02) · 067-068
DOI: 10.1055/a-2536-9554 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuropediatrics, erschienen am 01.04.2025. Verfasst von Ingo Borggraefe und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Neurology, Department of Pediatrics, Developmental Medicine and Social Pediatrics, Ludwig Maximilian University Munich, Dr. von…. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of Pediatric Neurology, Department of Pediatrics, Developmental Medicine and Social Pediatrics, Ludwig Maximilian University Munich, Dr. von Hauner Children's Hospital, University Hospital, Munich, Germany.
- Comprehensive Epilepsy Center for Children and Adolescents, Ludwig Maximilians University Munich, University Hospital, Munich, Germany.
- University Children's Hospital Salzburg, Paracelsus Medical University (PMU), Salzburg, Austria.
Zitieren
APA
Borggraefe, I., & Wortmann, S. (2025). Advancing Precision Therapies in Neurogenetic Disorders and the Treatment of Medically Refractory Epilepsies. Neuropediatrics, 56(02), 067-068. https://doi.org/10.1055/a-2536-9554
Vancouver
Borggraefe I, Wortmann S. Advancing Precision Therapies in Neurogenetic Disorders and the Treatment of Medically Refractory Epilepsies. Neuropediatrics. 2025;56(02):067-068. doi:10.1055/a-2536-9554
BibTeX
@article{Borggraefe2025,
author = {Borggraefe, Ingo and Wortmann, Saskia},
title = {Advancing Precision Therapies in Neurogenetic Disorders and the Treatment of Medically Refractory Epilepsies},
journal = {Neuropediatrics},
year = {2025},
volume = {56},
number = {02},
pages = {067--068},
doi = {10.1055/a-2536-9554}
}
EUVIMED